IE
ZYBT

Israel Englander’s Zhengye Biotechnology Holding ZYBT Stock Holding History

Israel Englander’s Portfolio ZYBT Stock Details ZYBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,602
Closed -$38.3K – 6585
2025
Q3 		$38.3K Buy
+14,602
New +$101K ﹤0.01% 5824

Other funds holding ZYBT

WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Israel Englander's ZYBT Position: Q4 2025 in Review

Israel Englander sold out of Zhengye Biotechnology Holding (ZYBT) in Q4 2025, closing a stake of 14,602 shares — an estimated $38.3K sold.

Israel Englander first reported a position in ZYBT in Q3 2025 and held it in 1 quarter. The position peaked at $38.3K in Q3 2025. 11 funds tracked by Wall St. Rank hold ZYBT as of Q4 2025.

  • Israel Englander reported no remaining Zhengye Biotechnology Holding position as of Q4 2025 after selling out during the quarter.
  • Israel Englander sold 14,602 Zhengye Biotechnology Holding shares in Q4 2025, an estimated $38.3K.
  • Israel Englander first reported a position in Zhengye Biotechnology Holding in Q3 2025 and held it in 1 quarter.
  • Israel Englander's Zhengye Biotechnology Holding position peaked at $38.3K in Q3 2025.
  • 11 funds tracked by Wall St. Rank held Zhengye Biotechnology Holding as of Q4 2025.

Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.